Literature DB >> 21345164

Oxidative stress impairs endothelial nitric oxide levels in Behçets' disease.

Ece Onur1, Ceyda Kabaroglu, Isil Inanir, Ahmet Var, Yesim Guvenc, Ozlem Gunay, Kamer Gunduz.   

Abstract

BACKGROUND: Behçet's disease (BD) is an inflammatory vasculitis. Endogenous nitric oxide (NO), produced by endothelial cells, has pleiotropic effects such as vasodilatator, antiplatelet, antiproliferative. Reactive oxygen species (ROS) are produced at sites of endothelial inflammation. ROS target polyunsaturated lipids, which results in malondialdehyde (MDA) production.
OBJECTIVE: The aim was to investigate the oxidative stress in BD patients by measuring MDA and total antioxidant status (TAS) levels and to establish a possible relationship with respect to NO levels regarding disease activity.
MATERIALS AND METHODS: 55 BD patients (30 active/25 inactive) and 20 healthy volunteers were included in the study. Blood samples were drawn following an overnight fasting. TAS and MDA levels were determined spectrophotometrically. Serum nitrite (NO(2-)) and nitrate (NO(3-)) levels were measured to estimate NO production. Data were expressed as mean ± SD.
RESULTS: TAS levels were significantly lower in BD patients than the controls (1.19 ± 0.34 vs. 3.29 ± 0.89 mmol/L). In the active BD group, MDA levels (0.36 ± 0.19 nmol/mL) were significantly higher than both the inactive BD group (0.25 ± 0.18 nmol/mL) and controls (0.18 ± 0.41 nmol/mL). NO levels were significantly lower in the active group compared to the inactive group (18.0 ± 2.80 vs. 19.40 ± 2.70 µmol/L). MDA levels correlated negatively with NO levels in the active group.
CONCLUSION: Decreased NO levels mediated by increased oxidative stress significantly contribute to endothelial dysfunction observed in BD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345164     DOI: 10.3109/15569527.2011.554480

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  10 in total

1.  Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.

Authors:  Murat Yuksel; Abdulkadir Yildiz; Mustafa Oylumlu; Fatih Mehmet Turkcu; Mehmet Zihni Bilik; Aysun Ekinci; Bilal Elbey; Ebru Tekbas; Sait Alan
Journal:  Clin Rheumatol       Date:  2015-03-07       Impact factor: 2.980

2.  Association of Rho-kinase 1 (ROCK1) gene polymorphisms with Behçet's disease.

Authors:  Elif Oguz; Abdullah Tuncay Demiryürek; Yavuz Pehlivan; Bünyamin Kisacik; Esma Ozkara; Serdar Oztuzcu; Belgin Alasehirli; Ahmet Mesut Onat
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

3.  [Clinical analysis of golimumab in the treatment of severe/refractory cardiovascular involvement in Behcet syndrome].

Authors:  L X Sun; J J Liu; Y X Hou; C R Li; L Li; X P Tian; X F Zeng; W J Zheng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

Review 4.  Oxidative stress in oral diseases.

Authors:  A H Kesarwala; M C Krishna; J B Mitchell
Journal:  Oral Dis       Date:  2015-01-19       Impact factor: 3.511

5.  Thiol/disulfide homeostasis in patients with ocular-active and ocular-inactive Behçet disease.

Authors:  Mehmet Balbaba; Fatih Ulaş; Hakan Yıldırım; Adem Soydan; Ali Dal; Süleyman Aydın
Journal:  Int Ophthalmol       Date:  2020-06-01       Impact factor: 2.031

6.  Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease.

Authors:  Mehtap Bozkurt; Hatice Yüksel; Serda Em; Pelin Oktayoglu; Mehmet Yildiz; Dicle Akdeniz; Kemal Nas
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

7.  Thrombosis in vasculitis: from pathogenesis to treatment.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Amedeo Amedei; Elena Niccolai; Mario Milco D'Elios; Chiara Della Bella; Alessia Grassi; Matteo Becatti; Claudia Fiorillo; Lorenzo Emmi; Augusto Vaglio; Domenico Prisco
Journal:  Thromb J       Date:  2015-04-16

8.  TWEAK enhances E-selectin and ICAM-1 expression, and may contribute to the development of cutaneous vasculitis.

Authors:  Tao Chen; Zai-pei Guo; Li Li; Meng-meng Li; Ting-ting Wang; Rui-zhen Jia; Na Cao; Jing-yi Li
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

Review 9.  Understanding Behçet's Disease in the Context of Innate Immunity Activation.

Authors:  Sandro F Perazzio; Luis E C Andrade; Alexandre W S de Souza
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

10.  Endocan Measurement for Active Behçet Disease.

Authors:  Ayhan Kul; Orhan Ateş; Meltem Alkan Melikoğlu; Mahir Uğur; Nurinnisa Öztürk; Gülsüm Erkayhan; İbrahim Koçer
Journal:  Arch Rheumatol       Date:  2017-03-24       Impact factor: 1.472

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.